Skip to content

Nevirapine-based triple-drug combinations safe for use in pregnant African women

Warning issued over bleeding within the skull in patients taking tipranavir

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI or d4T cautiously'

Mortality and causes of death amongst people taking HIV treatment in Senegal examined

Fat loss beginning to trigger treatment changes in South African patients

Liver damage linked to ddI exposure in small series of Spanish patients

Genetic testing can predict who is at risk of abacavir hypersensitivity

1% of patients at French hospital develop rash after starting treatment with atazanavir

Study finds no link between efavirenz use and depression